Multiple myeloma and amyloidosis begin the same way – in plasma cells, white blood cells that help your immune system. But multiple myeloma (MM) is a rare blood cancer while amyloidosis is a ...

Amyloidosis is a condition associated with multiple myeloma. In amyloidosis, the abnormal plasma cells create many light-chain proteins that can form amyloid deposits.

Multiple myeloma and AL amyloidosis link to plasma cells in the bone marrow. The conditions co-occur in 10–15% of people with MM. Read about the connection.

People often have both amyloidosis and multiple myeloma. Anemia: It's one of the symptoms of multiple myeloma. It happens when too few red blood cells are in your body.

As CAR T-cell therapy has become a transformative option in multiple myeloma, a first-of-its-kind trial now extends that potential to relapsed/refractory light chain (AL) amyloidosis.

For decades, the diagnosis of multiple myeloma required evidence of end-organ damage characterized by myeloma-defining events ...

"We want to cure multiple myeloma, one way or another," S. Vincent Rajkumar, MD, chair of the Myeloma Amyloidosis Dysproteinemia Group at Mayo Clinic in Rochester, Minnesota, told MedPage Today ...

Ríos-Tamayo R, Krsnik I, Gómez-Bueno M, et al. AL amyloidosis and multiple myeloma: A complex scenario in which cardiac involvement remains the key prognostic factor. Life (Basel) . 2023;13(7):1518.

Darzalex is a monoclonal antibody used to treat adults with multiple myeloma and light chain amyloidosis.. Good Response to Treatment. Daratumumab attaches to the CD38 protein, found in large ...

This multiple myeloma staging system, introduced in 1975 and updated in 2006, remains in use by physicians who find it helpful in determining the extent of the disease.

"We want to cure multiple myeloma, one way or another," S. Vincent Rajkumar, MD, chair of the Myeloma Amyloidosis Dysproteinemia Group at Mayo Clinic in Rochester, Minnesota, told MedPage Today.